Miki Katoh
- Pharmacology top 0.1%
- Oncology top 5%
- Molecular Biology top 10%
- Pediatrics, Perinatology and Child Health top 2%
- Pharmacology top 5%
- Co-authors
- Tsuyoshi YokoiMiki NakajimaHiroshi YamazakiHiroyuki YamanakaChise TatenoKatsutoshi YoshizatoMasayuki NadaiTatsuki Fukami
- Topics
- Pharmacogenetics and Drug Metabolism (46 papers)Drug Transport and Resistance Mechanisms (30 papers)Pharmacological Effects and Toxicity Studies (12 papers)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Miki Katoh
85 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 112
- Pharmacology 1.2k
- Oncology 949
- Molecular Biology 827
- Pediatrics, Perinatology and Child Health 469
- Pharmacology 247
Countries citing papers authored by Miki Katoh
This map shows the geographic impact of Miki Katoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miki Katoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miki Katoh more than expected).
Fields of papers citing papers by Miki Katoh
This network shows the impact of papers produced by Miki Katoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miki Katoh. The network helps show where Miki Katoh may publish in the future.
Co-authorship network of co-authors of Miki Katoh
This figure shows the co-authorship network connecting the top 25 collaborators of Miki Katoh. A scholar is included among the top collaborators of Miki Katoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miki Katoh. Miki Katoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 22 | |
| 5 | 14 | |
| 6 | 12 | |
| 7 | 2 | |
| 8 | 9 | |
| 9 | 56 | |
| 10 | 20 | |
| 11 | 68 | |
| 12 | 37 | |
| 13 | 7 | |
| 14 | 32 | |
| 15 | 7 | |
| 16 | 21 | |
| 17 | 51 | |
| 18 | 89 | |
| 19 | 105 | |
| 20 | 70 |
About Miki Katoh
Miki Katoh is a scholar working on Pharmacology, Oncology and Biochemistry, having authored 86 papers that have together received 2.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (46 papers), Drug Transport and Resistance Mechanisms (30 papers) and Pharmacological Effects and Toxicity Studies (12 papers). The work is most often cited by research in Pharmacology (1.2k citations), Oncology (949 citations) and Pediatrics, Perinatology and Child Health (469 citations). Miki Katoh has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Tsuyoshi Yokoi, Miki Nakajima, Hiroshi Yamazaki, Hiroyuki Yamanaka, Chise Tateno, Katsutoshi Yoshizato, Masayuki Nadai, Tatsuki Fukami, Sumie Yoshitomi and Toshiyuki Takeuchi. Their work appears in journals such as Journal of Biological Chemistry, International Journal of Cancer and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.